The mutation was detected last fall. It can reduce the use of drugs from the coronavirus.
Scientists at the California Institute of Technology and Columbia University in a new study found that a new strain of coronavirus spread in New York reduces the effectiveness of COVID-drugs, writes The New York Times.
Experts identified the mutation in November 2020. In February, experts, guided by the data of the international database GISAID, determined that the share of genomes of this strain of infection among those registered in the metropolis is 27%.
It is known that B. 1. 526 contains, among other things, the E484K mutation, due to which new variants of the coronavirus evade the immune response.
In addition, the new mutation may cause a decrease in the effectiveness and benefit of COVID-19 vaccines.